HCMT
AERI

Highland Capital Management (Tennessee)’s Aerie Pharmaceuticals AERI Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,000
Closed -$53K – 594
2015
Q3 		$53K Buy
+3,000
New +$54.3K ﹤0.01% 368

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Highland Capital Management (Tennessee)'s AERI Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of Aerie Pharmaceuticals (AERI) in Q4 2015, closing a stake of 3,000 shares — an estimated $53K sold.

Highland Capital Management (Tennessee) first reported a position in AERI in Q3 2015 and held it in 1 quarter. The position peaked at $53K in Q3 2015. 116 funds tracked by Wall St. Rank hold AERI as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining Aerie Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 3,000 Aerie Pharmaceuticals shares in Q4 2015, an estimated $53K.
  • Highland Capital Management (Tennessee) first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s Aerie Pharmaceuticals position peaked at $53K in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.